ATRICURE INC (ATRC) Stock Price & Overview
NASDAQ:ATRC • US04963C2098
Current stock price
The current stock price of ATRC is 29.4 USD. Today ATRC is up by 2.58%. In the past month the price decreased by -3.42%. In the past year, price decreased by -8.15%.
ATRC Key Statistics
- Market Cap
- 1.464B
- P/E
- N/A
- Fwd P/E
- 438.65
- EPS (TTM)
- -0.13
- Dividend Yield
- N/A
ATRC Stock Performance
ATRC Stock Chart
ATRC Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ATRC. When comparing the yearly performance of all stocks, ATRC is a bad performer in the overall market: 84.21% of all stocks are doing better.
ATRC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ATRC. While ATRC has a great health rating, there are worries on its profitability.
ATRC Earnings
On February 17, 2026 ATRC reported an EPS of 0.04 and a revenue of 140.50M. The company beat EPS expectations (141.28% surprise) and missed revenue expectations (-1.45% surprise).
ATRC Forecast & Estimates
15 analysts have analysed ATRC and the average price target is 51.26 USD. This implies a price increase of 74.34% is expected in the next year compared to the current price of 29.4.
For the next year, analysts expect an EPS growth of 151.56% and a revenue growth 13.14% for ATRC
ATRC Groups
Sector & Classification
ATRC Financial Highlights
Over the last trailing twelve months ATRC reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 81.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.75% | ||
| ROE | -2.33% | ||
| Debt/Equity | 0.14 |
ATRC Ownership
ATRC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.72 | 174.966B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.72 | 163.009B | ||
| SYK | STRYKER CORP | 22.87 | 132.986B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.3 | 93.897B | ||
| IDXX | IDEXX LABORATORIES INC | 39.44 | 45.587B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.96 | 45.039B | ||
| BDX | BECTON DICKINSON AND CO | 11.41 | 44.257B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 33.688B | ||
| RMD | RESMED INC | 18.79 | 33.544B | ||
| DXCM | DEXCOM INC | 24.75 | 24.292B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.38 | 18.455B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.08 | 13.926B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ATRC
Company Profile
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,350 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Company Info
IPO: 2005-08-05
ATRICURE INC
7555 Innovation Way
Mason OHIO 45040 US
CEO: Michael H. Carrel
Employees: 1350
Phone: 15137554100
ATRICURE INC / ATRC FAQ
What does ATRC do?
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,350 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Can you provide the latest stock price for ATRICURE INC?
The current stock price of ATRC is 29.4 USD. The price increased by 2.58% in the last trading session.
Does ATRICURE INC pay dividends?
ATRC does not pay a dividend.
What is the ChartMill technical and fundamental rating of ATRC stock?
ATRC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Should I buy ATRC stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ATRC.
What is the expected growth for ATRC stock?
The Revenue of ATRICURE INC (ATRC) is expected to grow by 13.14% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
How many employees does ATRICURE INC have?
ATRICURE INC (ATRC) currently has 1350 employees.